Henipavirus pp 123-152 | Cite as

Nipah and Hendra Virus Interactions with the Innate Immune System

  • Christopher F. Basler
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 359)


Nipah virus and Hendra virus are related, highly pathogenic paramyxoviruses with unusually broad host ranges. Henipaviruses encode several proteins that block innate immune responses, and these are likely to serve as virulence factors. Specfically, four virus-encoded proteins, the phosphoprotein (P), the V protein, the W protein, and the C protein have each been demonstrated to counteract aspects of the interferon (IFN)-α/β response, a key component of the innate immune response to virus infection. The available data indicate that V and W can inhibit the production of IFNα/β in response to various stimuli, while the P, V, and W proteins also block the ability of IFNs to signal and induce an antiviral state in cells. The C protein also inhibits the antiviral effects of IFNα/β by a poorly characterized mechanism. Reverse genetics systems, which allow the generation of recombinant viruses bearing specific mutations, have demonstrated the importance of the viral IFN-antagonists for replication. With these systems in hand, the field is now poised to define how specific viral IFN-antagonist functions influence viral pathogenesis.


Newcastle Disease Virus TLR3 Signaling Editing Site Helicase Domain Versus Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, MDA-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 101:17264–17269PubMedGoogle Scholar
  2. Baum A, Sachidanandam R, Garcia-Sastre A (2010) Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A 107:16303–16308PubMedGoogle Scholar
  3. Biron CA (2001) Interferons alpha and beta as immune regulators—a new look. Immunity 14:661–664PubMedGoogle Scholar
  4. Bousse T, Chambers RL, Scroggs RA, Portner A, Takimoto T (2006) Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment. Virus Res 121:23–32PubMedGoogle Scholar
  5. Boxer EL, Nanda SK, Baron MD (2009) The rinderpest virus non-structural C protein blocks the induction of type 1 interferon. Virology 385:134–142PubMedGoogle Scholar
  6. Caignard G, Guerbois M, Labernardiere JL, Jacob Y, Jones LM, Wild F, Tangy F, Vidalain PO (2007) Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling. Virology 368:351–362PubMedGoogle Scholar
  7. Caignard G, Bourai M, Jacob Y, Tangy F, Vidalain PO (2009a) Inhibition of IFN-alpha/beta signaling by two discrete peptides within measles virus V protein that specifically bind STAT1 and STAT2. Virology 383:112–120PubMedGoogle Scholar
  8. Caignard G, Komarova AV, Bourai M, Mourez T, Jacob Y, Jones LM, Rozenberg F, Vabret A, Freymuth F, Tangy F, Vidalain PO (2009b) Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor. PLoS Pathog 5:e1000587PubMedGoogle Scholar
  9. Chambers R, Takimoto T (2009a) Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products. J Gen Virol 90:1906–1915PubMedGoogle Scholar
  10. Chambers R, Takimoto T (2009b) Antagonism of innate immunity by paramyxovirus accessory proteins. Viruses 1:574–593PubMedGoogle Scholar
  11. Childs K, Stock N, Ross C, Andrejeva J, Hilton L, Skinner M, Randall R, Goodbourn S (2007) mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359:190–200PubMedGoogle Scholar
  12. Childs KS, Andrejeva J, Randall RE, Goodbourn S (2009) Mechanism of mda-5 Inhibition by paramyxovirus V proteins. J Virol 83:1465–1473PubMedGoogle Scholar
  13. Ciancanelli MJ, Volchkova VA, Shaw ML, Volchkov VE, Basler CF (2009) Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism. J VirolGoogle Scholar
  14. Crameri G, Todd S, Grimley S, McEachern JA, Marsh GA, Smith C, Tachedjian M, De Jong C, Virtue ER, Yu M, Bulach D, Liu JP, Michalski WP, Middleton D, Field HE, Wang LF (2009) Establishment, immortalisation and characterisation of pteropid bat cell lines. PLoS ONE 4:e8266PubMedGoogle Scholar
  15. Devaux P, von Messling V, Songsungthong W, Springfeld C, Cattaneo R (2007) Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology 360:72–83PubMedGoogle Scholar
  16. Didcock L, Young DF, Goodbourn S, Randall RE (1999) The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 73:9928–9933PubMedGoogle Scholar
  17. Fontana JM, Bankamp B, Bellini WJ, Rota PA (2008) Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus. Virology 374: 71–81Google Scholar
  18. Gale M Jr, Sen GC (2009) Viral evasion of the interferon system. J Interferon Cytokine Res 29:475–476PubMedGoogle Scholar
  19. Garcin D, Latorre P, Kolakofsky D (1999) Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J Virol 73:6559–6565PubMedGoogle Scholar
  20. Garcin D, Curran J, Kolakofsky D (2000) Sendai virus C proteins must interact directly with cellular components to interfere with interferon action. J Virol 74:8823–8830PubMedGoogle Scholar
  21. Garcin D, Curran J, Itoh M, Kolakofsky D (2001) Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. J Virol 75:6800–6807PubMedGoogle Scholar
  22. Garcin D, Marq JB, Goodbourn S, Kolakofsky D (2003) The amino-terminal extensions of the longer Sendai virus C proteins modulate pY701-Stat1 and bulk Stat1 levels independently of interferon signaling. J Virol 77:2321–2329PubMedGoogle Scholar
  23. Georges-Courbot MC, Contamin H, Faure C, Loth P, Baize S, Leyssen P, Neyts J, Deubel V (2006) Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection. Antimicrob Agents Chemother 50:1768–1772PubMedGoogle Scholar
  24. Gonzalez-Navajas JM, Lee J, David M, Raz E (2010) Immunomodulatory functions of type I interferons. Nat Rev ImmunolGoogle Scholar
  25. Goodbourn S, Randall RE (2009) The regulation of type I interferon production by paramyxoviruses. J Interferon Cytokine Res 29:539–547PubMedGoogle Scholar
  26. Gotoh B, Takeuchi K, Komatsu T, Yokoo J, Kimura Y, Kurotani A, Kato A, Nagai Y (1999) Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett 459:205–210PubMedGoogle Scholar
  27. Gotoh B, Takeuchi K, Komatsu T, Yokoo J (2003) The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J Virol 77:3360–3370PubMedGoogle Scholar
  28. Habjan M, Andersson I, Klingstrom J, Schumann M, Martin A, Zimmermann P, Wagner V, Pichlmair A, Schneider U, Muhlberger E, Mirazimi A, Weber F (2008) Processing of genome 5’ termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 3:e2032PubMedGoogle Scholar
  29. Hagmaier K, Stock N, Goodbourn S, Wang LF, Randall R (2006) A single amino acid substitution in the V protein of Nipah virus alters its ability to block interferon signalling in cells from different species. J Gen Virol 87:3649–3653PubMedGoogle Scholar
  30. Hagmaier K, Stock N, Precious B, Childs K, Wang LF, Goodbourn S, Randall RE (2007) Mapuera virus, a rubulavirus that inhibits interferon signalling in a wide variety of mammalian cells without degrading STATs. J Gen Virol 88:956–966PubMedGoogle Scholar
  31. Halpin K, Bankamp B, Harcourt BH, Bellini WJ, Rota PA (2004) Nipah virus conforms to the rule of six in a minigenome replication assay. J Gen Virol 85:701–707PubMedGoogle Scholar
  32. Harcourt BH, Tamin A, Ksiazek TG, Rollin PE, Anderson LJ, Bellini WJ, Rota PA (2000) Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology 271:334–349PubMedGoogle Scholar
  33. He B, Paterson RG, Stock N, Durbin JE, Durbin RK, Goodbourn S, Randall RE, Lamb RA (2002) Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology 303:15–32PubMedGoogle Scholar
  34. Hoebe K, Beutler B (2004) LPS, dsRNA and the interferon bridge to adaptive immune responses: Trif, Tram, and other TIR adaptor proteins. J Endotoxin Res 10:130–136PubMedGoogle Scholar
  35. Huang Z, Krishnamurthy S, Panda A, Samal SK (2003) Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist. J Virol 77:8676–8685PubMedGoogle Scholar
  36. Jensen S, Thomsen AR (2012) Sensing of RNA viruses-A review on innate immune receptors invovled in recognizing RNA virus invasion. J Virol 86:2900–2910 PubMedGoogle Scholar
  37. Kato A, Ohnishi Y, Kohase M, Saito S, Tashiro M, Nagai Y (2001) Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J Virol 75:3802–3810PubMedGoogle Scholar
  38. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6:981–988PubMedGoogle Scholar
  39. Komatsu T, Takeuchi K, Yokoo J, Tanaka Y, Gotoh B (2000) Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription [in process citation]. J Virol 74:2477–2480PubMedGoogle Scholar
  40. Komatsu T, Takeuchi K, Yokoo J, Gotoh B (2002) Sendai virus C protein impairs both phosphorylation and dephosphorylation processes of Stat1. FEBS Lett 511:139–144PubMedGoogle Scholar
  41. Komatsu T, Takeuchi K, Yokoo J, Gotoh B (2004) C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production. Virology 325:137–148PubMedGoogle Scholar
  42. Komatsu T, Takeuchi K, Gotoh B (2007) Bovine parainfluenza virus type 3 accessory proteins that suppress beta interferon production. Microbes Infect 9:954–962PubMedGoogle Scholar
  43. Ksiazek TG, Rota PA, Rollin PE (2011) A review of Nipah and Hendra viruses with an historical aside. Virus Res 162:173–183PubMedGoogle Scholar
  44. Kubota T, Yokosawa N, Yokota S, Fujii N (2001) C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha. Biochem Biophys Res Commun 283:255–259PubMedGoogle Scholar
  45. Kubota T, Yokosawa N, Yokota S, Fujii N (2002) Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the alpha interferon receptor complex. J Virol 76:12676–12682PubMedGoogle Scholar
  46. Kulkarni S, Volchkova V, Basler CF, Palese P, Volchkov VE, Shaw ML (2009) Nipah virus edits its P gene at high frequency to express the V and W proteins. J Virol 83:3982–3987PubMedGoogle Scholar
  47. Lamb RA, Parks GD (2007) Paramyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields Virology, 5th edn, vol 1. Lippincott Williams and Wilkins, PhiladelphiaGoogle Scholar
  48. Li T, Chen X, Garbutt KC, Zhou P, Zheng N (2006) Structure of DDB1 in complex with a paramyxovirus V protein: viral hijack of a propeller cluster in ubiquitin ligase. Cell 124:105–117PubMedGoogle Scholar
  49. Liston P, Briedis DJ (1994) Measles virus V protein binds zinc. Virology 198:399–404PubMedGoogle Scholar
  50. Lo MK, Harcourt BH, Mungall BA, Tamin A, Peeples ME, Bellini WJ, Rota PA (2009) Determination of the henipavirus phosphoprotein gene mRNA editing frequencies and detection of the C, V and W proteins of Nipah virus in virus-infected cells. J Gen Virol 90:398–404PubMedGoogle Scholar
  51. Lo MK, Miller D, Aljofan M, Mungall BA, Rollin PE, Bellini WJ, Rota PA (2010) Characterization of the antiviral and inflammatory responses against Nipah virus in endothelial cells and neurons. Virology 404:78–88PubMedGoogle Scholar
  52. Lu LL, Puri M, Horvath CM, Sen GC (2008) Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1. J Biol Chem 283:14269–14276PubMedGoogle Scholar
  53. Ludlow LE, Lo MK, Rodriguez JJ, Rota PA, Horvath CM (2008) Henipavirus V protein association with Polo-like kinase reveals functional overlap with STAT1 binding and interferon evasion. J Virol 82:6259–6271PubMedGoogle Scholar
  54. Malur AG, Chattopadhyay S, Maitra RK, Banerjee AK (2005) Inhibition of STAT 1 phosphorylation by human parainfluenza virus type 3 C protein. J Virol 79:7877–7882PubMedGoogle Scholar
  55. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167–1172PubMedGoogle Scholar
  56. Middleton DJ, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, Westbury HA, Halpin K, Daniels PW (2007) Experimental Nipah virus infection in pteropid bats (Pteropus poliocephalus). J Comp Pathol 136:266–272PubMedGoogle Scholar
  57. Nishio M, Garcin D, Simonet V, Kolakofsky D (2002) The carboxyl segment of the mumps virus V protein associates with Stat proteins in vitro via a tryptophan-rich motif. Virology 300:92–99PubMedGoogle Scholar
  58. Nishio M, Tsurudome M, Ito M, Garcin D, Kolakofsky D, Ito Y (2005a) Identification of paramyxovirus V protein residues essential for STAT protein degradation and promotion of virus replication. J Virol 79:8591–8601PubMedGoogle Scholar
  59. Nishio M, Tsurudome M, Ito M, Ito Y (2005b) Human parainfluenza virus type 4 is incapable of evading the interferon-induced antiviral effect. J Virol 79:14756–14768PubMedGoogle Scholar
  60. Ohno S, Ono N, Takeda M, Takeuchi K, Yanagi Y (2004) Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J Gen Virol 85:2991–2999PubMedGoogle Scholar
  61. O’Neill LA, Bowie AG (2011) The powerstroke and camshaft of the RIG-I antiviral RNA detection machine. Cell 147:259–261PubMedGoogle Scholar
  62. Palosaari H, Parisien JP, Rodriguez JJ, Ulane CM, Horvath CM (2003) STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J Virol 77:7635–7644PubMedGoogle Scholar
  63. Parisien JP, Lau JF, Rodriguez JJ, Sullivan BM, Moscona A, Parks GD, Lamb RA, Horvath CM (2001) The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 283:230–239PubMedGoogle Scholar
  64. Parisien JP, Lau JF, Horvath CM (2002a) STAT2 Acts as a Host Range Determinant for Species-Specific Paramyxovirus Interferon Antagonism and Simian Virus 5 Replication. J Virol 76:6435–6441PubMedGoogle Scholar
  65. Parisien JP, Lau JF, Rodriguez JJ, Ulane CM, Horvath CM (2002b) Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction. J Virol 76:4190–4198PubMedGoogle Scholar
  66. Parisien JP, Bamming D, Komuro A, Ramachandran A, Rodriguez JJ, Barber G, Wojahn RD, Horvath CM (2009) A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2. J Virol 83:7252–7260PubMedGoogle Scholar
  67. Park M-S, Shaw ML, Munoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, Garcia-Sastre A, Basler CF (2003) Newcastle Disease Virus (NDV)-Based Assay Demonstrates Interferon-Antagonist Activity for the NDV V Protein and the Nipah Virus V, W, and C Proteins. J Virol 77:1501–1511PubMedGoogle Scholar
  68. Paterson RG, Leser GP, Shaughnessy MA, Lamb RA (1995) The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions. Virology 208:121–131PubMedGoogle Scholar
  69. Pfaller CK, Conzelmann KK (2008) Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction. J Virol 82:12365–12373PubMedGoogle Scholar
  70. Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375–386PubMedGoogle Scholar
  71. Poole E, He B, Lamb RA, Randall RE, Goodbourn S (2002) The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta. Virology 303:33–46PubMedGoogle Scholar
  72. Precious B, Childs K, Fitzpatrick-Swallow V, Goodbourn S, Randall RE (2005a) Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1. J Virol 79:13434–13441PubMedGoogle Scholar
  73. Precious B, Young DF, Andrejeva L, Goodbourn S, Randall RE (2005b) In vitro and in vivo specificity of ubiquitination and degradation of STAT1 and STAT2 by the V proteins of the paramyxoviruses simian virus 5 and human parainfluenza virus type 2. J Gen Virol 86:151–158PubMedGoogle Scholar
  74. Precious BL, Carlos TS, Goodbourn S, Randall RE (2007) Catalytic turnover of STAT1 allows PIV5 to dismantle the interferon-induced anti-viral state of cells. Virology 368:114–121PubMedGoogle Scholar
  75. Ramachandran A, Horvath CM (2009) Paramyxovirus disruption of interferon signal transduction: STATus report. J Interferon Cytokine Res 29:531–537PubMedGoogle Scholar
  76. Ramachandran A, Horvath CM (2010) Dissociation of paramyxovirus interferon evasion activities: universal and virus-specific requirements for conserved V protein amino acids in MDA5 interference. J Virol 84:11152–11163PubMedGoogle Scholar
  77. Ramachandran A, Parisien JP, Horvath CM (2008) STAT2 is a primary target for measles virus V protein-mediated alpha/beta interferon signaling inhibition. J Virol 82:8330–8338PubMedGoogle Scholar
  78. Rodriguez JJ, Parisien JP, Horvath CM (2002) Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol 76:11476–11483PubMedGoogle Scholar
  79. Rodriguez JJ, Wang LF, Horvath CM (2003) Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J Virol 77:11842–11845PubMedGoogle Scholar
  80. Rodriguez JJ, Cruz CD, Horvath CM (2004) Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion. J Virol 78:5358–5367PubMedGoogle Scholar
  81. Saito S, Ogino T, Miyajima N, Kato A, Kohase M (2002) Dephosphorylation failure of tyrosine-phosphorylated STAT1 in IFN- stimulated Sendai virus C protein-expressing cells. Virology 293:205–209PubMedGoogle Scholar
  82. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454:523–527PubMedGoogle Scholar
  83. Schlee M, Roth A, Hornung V, Hagmann CA, Wimmenauer V, Barchet W, Coch C, Janke M, Mihailovic A, Wardle G, Juranek S, Kato H, Kawai T, Poeck H, Fitzgerald KA, Takeuchi O, Akira S, Tuschl T, Latz E, Ludwig J, Hartmann G (2009) Recognition of 5’ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31:25–34PubMedGoogle Scholar
  84. Schmidt A, Schwerd T, Hamm W, Hellmuth JC, Cui S, Wenzel M, Hoffmann FS, Michallet MC, Besch R, Hopfner KP, Endres S, Rothenfusser S (2009) 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci U S A 106:12067–12072PubMedGoogle Scholar
  85. Schuhmann KM, Pfaller CK, Conzelmann KK (2011) The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity. J Virol 85: 3162–3171 Google Scholar
  86. Seth RB, Sun L, Ea CK, Chen ZJ (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669–682PubMedGoogle Scholar
  87. Seto J, Qiao L, Guenzel CA, Xiao S, Shaw ML, Hayot F, Sealfon SC (2010) Novel Nipah virus immune-antagonism strategy revealed by experimental and computational study. J Virol 84:10965–10973PubMedGoogle Scholar
  88. Shaffer JA, Bellini WJ, Rota PA (2003) The C protein of measles virus inhibits the type I interferon response. Virology 315:389–397PubMedGoogle Scholar
  89. Shaw ML, Garcia-Sastre A, Palese P, Basler CF (2004) Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol 78:5633–5641PubMedGoogle Scholar
  90. Shaw ML, Cardenas WB, Zamarin D, Palese P, Basler CF (2005) Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J Virol 79:6078–6088PubMedGoogle Scholar
  91. Sleeman K, Bankamp B, Hummel KB, Lo MK, Bellini WJ, Rota PA (2008) The C, V and W proteins of Nipah virus inhibit minigenome replication. J Gen Virol 89:1300–1308PubMedGoogle Scholar
  92. Sparrer KM, Pfaller CK, Conzelmann KK (2012) Measles virus C protein interferes with Beta interferon transcription in the nucleus. J Virol 86: 796–805 Google Scholar
  93. Strahle L, Garcin D, Kolakofsky D (2006) Sendai virus defective-interfering genomes and the activation of interferon-beta. Virology 351:101–111PubMedGoogle Scholar
  94. Sun D, Luthra P, Li Z, He B (2009) PLK1 down-regulates parainfluenza virus 5 gene expression. PLoS Pathog 5:e1000525PubMedGoogle Scholar
  95. Takeuchi K, Komatsu T, Yokoo J, Kato A, Shioda T, Nagai Y, Gotoh B (2001) Sendai virus C protein physically associates with Stat1. Genes Cells 6:545–557PubMedGoogle Scholar
  96. Takeuchi K, Kadota SI, Takeda M, Miyajima N, Nagata K (2003) Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett 545:177–182PubMedGoogle Scholar
  97. Ulane CM, Horvath CM (2002) Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 304:160–166PubMedGoogle Scholar
  98. Ulane CM, Rodriguez JJ, Parisien JP, Horvath CM (2003) STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J Virol 77:6385–6393PubMedGoogle Scholar
  99. Ulane CM, Kentsis A, Cruz CD, Parisien JP, Schneider KL, Horvath CM (2005) Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain. J Virol 79:10180–10189PubMedGoogle Scholar
  100. Van Cleve W, Amaro-Carambot E, Surman SR, Bekisz J, Collins PL, Zoon KC, Murphy BR, Skiadopoulos MH, Bartlett EJ (2006) Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1. Virology 352:61–73PubMedGoogle Scholar
  101. Virtue ER, Marsh GA, Baker ML, Wang LF (2011a) Interferon production and signaling pathways are antagonized during henipavirus infection of fruit bat cell lines. PLoS One 6:e22488PubMedGoogle Scholar
  102. Virtue ER, Marsh GA, Wang LF (2011b) Interferon signaling remains functional during henipavirus infection of human cell lines. J Virol 85:4031–4034PubMedGoogle Scholar
  103. Wang LF, Michalski WP, Yu M, Pritchard LI, Crameri G, Shiell B, Eaton BT (1998) A novel P/V/C gene in a new member of the Paramyxoviridae family, which causes lethal infection in humans, horses, and other animals. J Virol 72:1482–1490PubMedGoogle Scholar
  104. Wang YE, Park A, Lake M, Pentecost M, Torres B, Yun TE, Wolf MC, Holbrook MR, Freiberg AN, Lee B (2010) Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding. PLoS Pathog 6:e1001186PubMedGoogle Scholar
  105. Wong KT, Grosjean I, Brisson C, Blanquier B, Fevre-Montange M, Bernard A, Loth P, Georges-Courbot MC, Chevallier M, Akaoka H, Marianneau P, Lam SK, Wild TF, Deubel V (2003) A golden hamster model for human acute Nipah virus infection. Am J Pathol 163:2127–2137PubMedGoogle Scholar
  106. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19:727–740PubMedGoogle Scholar
  107. Yokosawa N, Yokota S, Kubota T, Fujii N (2002) C-terminal region of STAT-1alpha is not necessary for its ubiquitination and degradation caused by mumps virus V protein. J Virol 76:12683–12690PubMedGoogle Scholar
  108. Yokota S, Saito H, Kubota T, Yokosawa N, Amano K, Fujii N (2003) Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex. Virology 306:135–146PubMedGoogle Scholar
  109. Yokota S, Okabayashi T, Yokosawa N, Fujii N (2008) Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20. FASEB J 22:74–83PubMedGoogle Scholar
  110. Yoneda M, Fujita K, Sato H, Kai C (2009) Reverse genetics of Nipah virus to probe viral pathogenicity. Methods Mol Biol 515:329–337PubMedGoogle Scholar
  111. Yoneda M, Guillaume V, Sato H, Fujita K, Georges-Courbot MC, Ikeda F, Omi M, Muto-Terao Y, Wild TF, Kai C (2010) The nonstructural proteins of Nipah virus play a key role in pathogenicity in experimentally infected animals. PLoS ONE 5:e12709PubMedGoogle Scholar
  112. Yoneyama M, Fujita T (2009) RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 227:54–65PubMedGoogle Scholar
  113. Yoneyama M, Fujita T, Wang R (2012) Cytoplasmic sensing of viral double-stranded RNA and activation of innate immunity by RIG-I-like receptors innate immune regulation and cancer imunotherapy. Springer, New York, pp 51–60 Google Scholar
  114. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730–737PubMedGoogle Scholar
  115. Young DF, Didcock L, Goodbourn S, Randall RE (2000) Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269:383–390PubMedGoogle Scholar
  116. Young DF, Chatziandreou N, He B, Goodbourn S, Lamb RA, Randall RE (2001) Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. J Virol 75:3363–3370PubMedGoogle Scholar
  117. Yount JS, Gitlin L, Moran TM, Lopez CB (2008) MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai virus defective interfering particles. J Immunol 180:4910–4918PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Department of MicrobiologyMount Sinai School of MedicineNew YorkUSA

Personalised recommendations